Connection
Gregory Schwartz to Clinical Trials as Topic
This is a "connection" page, showing publications Gregory Schwartz has written about Clinical Trials as Topic.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.135 |
|
|
|
-
Nicholls SJ, Ray KK, Johansson JO, Gordon A, Sweeney M, Halliday C, Kulikowski E, Wong N, Kim SW, Schwartz GG. Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease. Am J Cardiovasc Drugs. 2018 Apr; 18(2):109-115.
Score: 0.111
-
Sweeney JP, Schwartz GG. Applying the results of large clinical trials in the management of acute myocardial infarction. West J Med. 1996 Mar; 164(3):238-48.
Score: 0.024